Merck announced Wednesday it has signed a licensing agreement with the United Nations-backed Medicines Patent Pool to boost access to its Covid-19 antiviral pill in poorer countries, a landmark deal at odds with the reticence of major vaccine makers to share their technology.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,